Skip to main content
FinSpry Logo
FinSpry
CSTL logo
CSTL
(NASDAQ)
Castle Biosciences, Inc.
$24.84-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Castle Biosciences, Inc. (CSTL) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Castle Biosciences, Inc. stock.

Analyst Consensus Rating

Investment consensus from 3 professional research analysts

Consensus Rating

Buy
Based on 3 unique analysts
(4 total ratings in last 90 days)
Low Confidence∞:1 Buy/Sell

Average Price Target

$47.67
↑ 91.91% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CSTL Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Catherine Ramsey
Baird
BuyMaintains
$41.00 → $44.00
Subbu Nambi
Guggenheim
Strong BuyMaintains
$43.00 → $47.00
Thomas Flaten
Lake Street
Strong BuyMaintains
$35.00 → $52.00
Subbu Nambi
Guggenheim
Strong BuyMaintains
$30.00 → $43.00

Frequently Asked Questions

What is the analyst consensus rating for CSTL?

The analyst consensus rating for CSTL is "Buy" based on 3 analyst recommendations.

What is the average price target for CSTL?

The average 12-month price target for CSTL is $47.67, representing an upside of 91.9% from the current price of $24.84.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.